Follitropin and disease progression Patient Reports February 12, 2012

Follitropin Side Effects Report #5423165-1
Follitropin side effect was reported by a Consumer or non-health professional from ITALY on Aug 14, 2007. Female patient, 36 years of age, was diagnosed with anovulatory cycle and was treated with Follitropin. After drug was administered, patient experienced the following side effects: disease progression, gallbladder enlargement, malignant neoplasm of ampulla of vater, metastases to liver, metastases to lymph nodes, neuroendocrine carcinoma, renal cyst, subileus. Follitropin dosage: unknown. During the same period patient was treated with CHORIONIC GONADOTROPIN, PROGESTERONE. Patient was hospitalized. Patient died.

Follitropin Side Effects Report #5526106-1
Follitropin side effect was reported by a Consumer or non-health professional from ITALY on Nov 11, 2007. Female patient, 36 years of age, was diagnosed with anovulatory cycle and was treated with Follitropin. After drug was administered, patient experienced the following side effects: disease progression, gallbladder disorder, malignant neoplasm of ampulla of vater, metastases to liver, metastases to lymph nodes, pancreatic neuroendocrine tumour, renal disorder. Follitropin dosage: unknown. During the same period patient was treated with CHORIONIC GONADOTROPIN, PROGESTERONE. Patient was hospitalized. Patient died.